158 related articles for article (PubMed ID: 36946586)
1. The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression.
Rathbun RC; Lewis MM; Yuet WC; Woo S; Miller JL; Skrepnek GH
Ann Pharmacother; 2023 Nov; 57(11):1264-1272. PubMed ID: 36946586
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
3. Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
Belaunzarán-Zamudio PF; Naranjo L; Caro-Vega Y; Castillo-Mancilla JR; Camiro-Zuñiga A; Fuentes-García R; Crabtree-Ramírez BE; Sierra-Madero JG
AIDS Res Hum Retroviruses; 2023 Mar; 39(3):136-144. PubMed ID: 36597354
[TBL] [Abstract][Full Text] [Related]
4. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.
Tsai AC; Weiser SD; Petersen ML; Ragland K; Kushel MB; Bangsberg DR
Arch Gen Psychiatry; 2010 Dec; 67(12):1282-90. PubMed ID: 21135328
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data.
Byrd KK; Hou JG; Hazen R; Kirkham H; Suzuki S; Clay PG; Bush T; Camp NM; Weidle PJ; Delpino A;
J Acquir Immune Defic Syndr; 2019 Nov; 82(3):245-251. PubMed ID: 31343455
[TBL] [Abstract][Full Text] [Related]
6. Self-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral Load.
Kabore L; Muntner P; Chamot E; Zinski A; Burkholder G; Mugavero MJ
J Int Assoc Provid AIDS Care; 2015; 14(2):156-62. PubMed ID: 25421930
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
9. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
10. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
Sutton SS; Magagnoli J; Hardin JW
Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
[TBL] [Abstract][Full Text] [Related]
11. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
Messou E; Chaix ML; Gabillard D; Minga A; Losina E; Yapo V; Kouakou M; Danel C; Sloan C; Rouzioux C; Freedberg KA; Anglaret X
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):356-64. PubMed ID: 21191309
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis.
Cooke CE; Lee HY; Xing S
J Manag Care Pharm; 2014 Jan; 20(1):86-92. PubMed ID: 24372462
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia.
Chkhartishvili N; Rukhadze N; Svanidze M; Sharvadze L; Dehovitz JA; Tsertsvadze T; McNutt LA; del Rio C
J Int AIDS Soc; 2014; 17(1):18885. PubMed ID: 24721464
[TBL] [Abstract][Full Text] [Related]
14. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study.
O'Halloran Leach E; Lu H; Caballero J; Thomas JE; Spencer EC; Cook RL
AIDS Res Ther; 2021 Jun; 18(1):36. PubMed ID: 34174904
[TBL] [Abstract][Full Text] [Related]
15. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
Lester RT; Ritvo P; Mills EJ; Kariri A; Karanja S; Chung MH; Jack W; Habyarimana J; Sadatsafavi M; Najafzadeh M; Marra CA; Estambale B; Ngugi E; Ball TB; Thabane L; Gelmon LJ; Kimani J; Ackers M; Plummer FA
Lancet; 2010 Nov; 376(9755):1838-45. PubMed ID: 21071074
[TBL] [Abstract][Full Text] [Related]
16. The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana.
Owusu LB; Ababio C; Boahene S; Zakaria AS; Emikpe AO; Dwumfour CK; Appiagyei KA; Apiribu F
BMC Public Health; 2023 Jun; 23(1):1113. PubMed ID: 37296400
[TBL] [Abstract][Full Text] [Related]
17. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
18. Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data.
Johnson LF; Kariminia A; Trickey A; Yiannoutsos CT; Ekouevi DK; Minga AK; Pascom ARP; Han WM; Zhang L; Althoff KN; Rebeiro PF; Murenzi G; Ross J; Hsiao NY; Marsh K
J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25776. PubMed ID: 34546623
[TBL] [Abstract][Full Text] [Related]
19. Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural Uganda.
Benitez AE; Musinguzi N; Bangsberg DR; Bwana MB; Muzoora C; Hunt PW; Martin JN; Haberer JE; Petersen ML
J Int AIDS Soc; 2020 Mar; 23(3):e25467. PubMed ID: 32202067
[TBL] [Abstract][Full Text] [Related]
20. High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa.
Castillo-Mancilla JR; Musinguzi N; Asiimwe S; Siedner MJ; Orrell C; Bangsberg DR; Haberer JE
HIV Med; 2022 May; 23(5):465-473. PubMed ID: 34704355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
